{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "02024483",
    "validDate": "2026-07-11 00:00:00.000",
    "issueDate": "2006-07-11 00:00:00.000",
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA00202448306",
    "prodNameC": "三水安莫西林-克拉維酸鉀 2：1",
    "prodNameE": "Amoxicillin Trihydrate-Clavulanate Potassium,Mixture 2：1",
    "indicationsName": [
        "葡萄球菌、鏈球菌、肺炎 雙球菌、腦膜炎球菌及其他具有感受性細菌所引起之感染症。"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": null,
            "packageUnit": "44"
        }
    ],
    "medMCode": "01",
    "maMedCode": null,
    "medDCode": "E",
    "ingredientsDesc": [
        "Amoxicillin contains not less than 512 μg and not more than 638 μg of C16H19N3O5S\/mg, calculated with reference to the anhydrous basis.\\nClavulanic acid contains not less than 256 μg and not more than 330 μg of C8H8KNO5\/mg, calculated with reference to the anhydrous basis."
    ],
    "restraintItemsCode": [
        "02"
    ],
    "applicantName": "百歐敏國際有限公司",
    "applicantAddr": "台北市中山區中山北路三段３０號１１樓之１",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "LEK PHARMACEUTICALS D.D.",
            "factoryAddr": "PERZONALI 47, 2391 PREVALJE, SLOVENIA",
            "factoryCompanyAddr": "VEROVSKOVA 57, 1526 LJUBLJANA, SLOVENIA",
            "countryCode": "SI",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FSI0002000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Amoxicillin contains not less than 512 μg and not more than 638 μg of C16H19N3O5S\/mg, calculated with reference to the anhydrous basis.\\nClavulanic acid contains not less than 256 μg and not more than 330 μg of C8H8KNO5\/mg, calculated with reference to the anhydrous basis.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [
        {
            "applicantName": "永信藥品工業股份有限公司",
            "certNo": "DHA00202448317",
            "approveDocNo": "1106022421",
            "authDate": "2021-07-11",
            "validDate": "2026-07-11"
        }
    ],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "J01CR02"
        }
    ]
}